| | LOC105376032, PAX5 (V164L +2 more) | Single nucleotide variant (missense variant +2 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +2 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant +2 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Neurodevelopmental disorder | |
| | LOC105376032, PAX5 (R140Q +2 more) | Single nucleotide variant (missense variant +1 more) | Inborn genetic diseases +1 more | |
| | | Single nucleotide variant (missense variant +3 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |
| | | Single nucleotide variant (intron variant) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |
| | | Single nucleotide variant (intron variant +1 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +2 more | GConflicting classifications of pathogenicity |
| | LOC105376032, PAX5 (G183S +2 more) | Single nucleotide variant (missense variant +2 more) | Leukemia, acute lymphoblastic, susceptibility to, 3 | |